1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

about

Vitamin D receptor: A novel therapeutic target for kidney diseases.

P2860

Q49985993-05BFDFB2-53C1-4AB5-B847-BAF3083E56B4

P2860

1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

Item

http://www.wikidata.org/entity/Q42679595

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@en

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@nl

type

Item

label

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@en

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@nl

prefLabel

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@en

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@nl

P1476

1,25(OH)2D3 treatment attenuat ...... esenchymal transition in mice.

@en

P2093

Jianfei Ma

http://www.w3.org/2001/XMLSchema#string

Lina Yang

http://www.w3.org/2001/XMLSchema#string

Wenyu Huang

http://www.w3.org/2001/XMLSchema#string

Xiuli Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Peritoneal Dialysis in Asia

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells.

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production

Vitamin D regulating TGF-β induced epithelial-mesenchymal transition

Effect of Vitamin D3 Supplementation in Combination with Weight Loss on Inflammatory Biomarkers in Postmenopausal Women: A Randomized Controlled Trial

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.

Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us?

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.

P304

3817-3824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2017.7096

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28765896

http://www.w3.org/2001/XMLSchema#string

P932

5646959

http://www.w3.org/2001/XMLSchema#string

1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

about

P2860

P2860

1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932